1-7 of 7
Aaron Moynahan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated Results from a Matching-Adjusted Indirect Comparison of Efficacy Outcomes for Isatuximab Plus Pomalidomide and Dexamethasone Versus Daratumumab Plus Pomalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma

Xavier Leleu, Thomas Delea, Patricia Guyot, Aaron Moynahan, Erin Singh, Christina Tekle, Peggy L Lin
Journal: Blood
Blood (2023) 142 (Supplement 1): 6732.
https://doi.org/10.1182/blood-2023-188703
Published: 2023
Journal Articles

Real-World Study of Patients with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma: Analysis across a Spectrum of Advanced Disease Stage Medicare Patients in the United States

Thomas Delea, Aaron Moynahan, Wenzhen Ge, Xue Song, Glenn S. Kroog, Irene Noguera-Troise, Karen Rodriguez Lorenc, Qiufei Ma
Journal: Blood
Blood (2023) 142 (Supplement 1): 3773.
https://doi.org/10.1182/blood-2023-188591
Published: 2023
Journal Articles

Incidence of Second Primary Malignancies in Medicare-Insured Patients in the US with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma

Sikander Ailawadhi, Thomas Delea, Aaron Moynahan, Wenzhen Ge, Christian Hampp, Alexi Archambault, Ning Wu, Karen Rodriguez Lorenc, Irene Noguera-Troise, Glenn S. Kroog, Yariv Houvras, Qiufei Ma
Journal: Blood
Blood (2023) 142 (Supplement 1): 912.
https://doi.org/10.1182/blood-2023-188562
Published: 2023
Journal Articles

Incidence of Second Primary Malignancies (SPMs) in Patients in the US with Triple-Class-Exposed (TCE) Relapsed or Refractory Multiple Myeloma (RRMM)

Wenzhen Ge, Alexi Archambault, Thomas E. Delea, Karen Rodriguez Lorenc, James Harnett, Aaron Moynahan, Derek Weycker, Yariv Houvras, Glenn S. Kroog, Ning Wu, Christian Hampp, Qiufei Ma
Journal: Blood
Blood (2022) 140 (Supplement 1): 10897–10899.
https://doi.org/10.1182/blood-2022-158013
Published: 2022
Journal Articles

Real-World Study of Patients with Triple-Class Exposed Relapsed or Refractory Multiple Myeloma: Analysis across a Spectrum of Advanced Disease Stage Patients in the United States

Qiufei Ma, Xue Song, Thomas E. Delea, Glenn S. Kroog, Wenzhen Ge, Lei Chi, Aaron Moynahan, Derek Weycker, Karen Rodriguez Lorenc
Journal: Blood
Blood (2022) 140 (Supplement 1): 5298–5300.
https://doi.org/10.1182/blood-2022-158142
Published: 2022
Journal Articles

The Impact of Hemoglobin Level on Risk of End-Organ Damage among Patients with Sickle Cell Disease - A Large-Scale, Longitudinal Analysis

William B Ershler, MD, Laura M De Castro, MD MHSc, Zahra Pakbaz, MD, Aaron Moynahan, Derek Weycker, PhD, Nhat Pham, Thomas E Delea, MSIA, Irene Agodoa, MD, Ze Cong, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-140572
Published: 2020
Journal Articles

Patterns of Medication Use in Patients with Relapsed and/or Refractory Multiple Myeloma

May Hagiwara, PhD, Aaron Moynahan, MA, Ze Cong, Yaozhu J. Chen, MPA, Emilie Duchesneau, BA, Dana Hurley, PharmD, MS, Thomas E. Delea, MSIA
Journal: Blood
Blood (2015) 126 (23): 4497.
https://doi.org/10.1182/blood.V126.23.4497.4497
Published: 2015